Veracyte, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on June 15, 2022. Veracyte, Inc. is a Delaware corporation with its principal executive offices in South San Francisco, California. The company's common stock trades on The Nasdaq Stock Market LLC under the symbol VCYT.
Financial Metrics
This filing does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
No material changes to financial operations or business strategy are reported in this filing. The document solely addresses corporate governance outcomes from the annual meeting.
Outlook, Risks, and Management Commentary
The filing details the successful ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022. Additionally, the stockholders approved, on a non-binding advisory basis, the compensation of the named executive officers. No specific risks, contingencies, or unusual items are disclosed in this report.
Key Facts for Investors
- Director Elections: Karin Eastham and Jens Holstein were elected as Class III Directors to serve until the 2025 Annual Meeting.
- Vote Breakdown (Directors): Karin Eastham received 52,211,923 votes for and 12,051,310 against. Jens Holstein received 64,322,026 votes for and 120,540 against.
- Auditor Ratification: Ernst & Young LLP was ratified with 67,194,440 votes for and 61,572 against.
- Executive Compensation: The "Say-on-Pay" proposal was approved with 59,077,731 votes for and 5,356,352 against.